Understanding GLP-1 Research Compounds

The receptor system

Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from intestinal L-cells in response to nutrient intake. Receptor agonists in this family have been studied extensively for their effects on insulin secretion, gastric motility, and satiety signaling.

First, second, and third generation

First-generation agonists target GLP-1 alone. Second-generation dual agonists add GIP receptor activity. Third-generation triple agonists, such as GLP-3 RT, additionally engage the glucagon receptor — a combination still under active investigation in published preclinical work.

What researchers are studying

Beyond glycemic endpoints, current literature explores GLP-1 pathway involvement in inflammation, cardiovascular markers, and neurodegeneration. The breadth of receptor expression across tissues makes this an unusually rich area for mechanistic study.

Reference material considerations

For comparability across experiments, lot-to-lot purity and sequence verification are non-negotiable. The PepsGPT catalog publishes HPLC and mass-spec data per lot so research groups can confirm identity before use.